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Objective: To examine whether nurse practitioner (NP)-assigned patients exhibited differences 
in utilization, costs and clinical outcomes compared to medical doctor (MD)-assigned patients.
Data Sources: Veterans Affairs (VA) administrative data capturing characteristics, outcomes 
and provider assignments of 806,434 VA patients assigned to an MD primary care provider 
(PCP) who left VA practice between 2010 and 2012. 
Study Design: We applied a difference-in-difference approach comparing outcomes between 
patients reassigned to MD and NP PCPs, respectively. We examined measures of outpatient 
(primary care, specialty care and mental health) and inpatient (total and ambulatory care 
sensitive hospitalizations) utilization, costs (outpatient, inpatient and total), and clinical 
outcomes (control of hemoglobin A1c, LDL and blood pressure) in the year following re-
assignment. 
Principal Findings: Compared to MD-assigned patients, NP-assigned patients were less likely 
to use primary care and specialty care services, and incurred fewer total and ambulatory care 
sensitive hospitalizations. Differences in costs, clinical outcomes and receipt of diagnostic tests 
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Conclusions: Patients reassigned to NPs experienced similar outcomes and incurred less 
utilization at comparable cost relative to MD patients. NPs may offer a cost-effective approach to 
addressing anticipated shortages of primary care physicians. 
Keywords: primary care, nurse practitioner, cost, quality of care, utilization, health workforce
INTRODUCTION
Nurse practitioners (NPs), accounting for about one-fifth of the primary care workforce 
in the United States (U.S.),1 serve a significant role in primary care delivery. The Veterans 
Health Administration (VA), one of the largest integrated healthcare systems in the U.S.,2 
employs more than 5,000 nurse practitioners in 142 VA medical centers (VAMCs) and over 800 
community-based outpatient clinics (CBOCs) across 50 states, the District of Columbia, and 
Puerto Rico.3 NPs in the VA play a key role in the delivery of team-based primary care, serving 
as primary care team leaders,4 and provide nearly 20% of primary care visits, approximately two 
million visits annually.2,5 VA is one of the largest employers of NPs in the U.S.
Several studies have identified current and expected future shortages of primary care 
physicians in the U.S. and increased use of NPs as primary care providers has been suggested as 
a potential solution to alleviate this shortage.6-8 Indeed, states have steadily increased the practice 
authority of NPs over the past decade.9 For national health care systems such as VA, NPs may 
offer cost-effective care delivery, as the average annual salary for NPs in the U.S. in 2017 was 
$107,480 compared to $198,370 for medical doctor (MD) general internists.10,11 NPs can 
increase primary care capacity provided they deliver care that is at least comparable to that of 
MDs. In addition, the broader use of NPs may only be more effective for subgroups within a 
patient population that include younger, less complex patients. This has been posed as a concern 
as NPs typically receive less extensive training and may be less equipped to care for more 
complex patients.12 
Previous research suggests that relative to MDs, NPs provide care with comparable 
clinical outcomes2 and quality of care,13-16 particularly for patients with chronic conditions.13-17 
However, prior observational studies used the observed care provided by an NP versus an MD as 
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of NP-provided care if more seriously ill patients self-selected to receive care from MDs. In 
addition, previous studies did not assess a comprehensive set of clinical and economic outcomes. 
In this study, we conducted a comprehensive assessment of patient outcomes between 
primary care NPs and MDs, including utilization, cost, and quality of care. To address patient 
selection bias, we applied a unique quasi-experimental approach. We identified patients who 
were reassigned to either an MD or an NP as their PCP after their prior MD provider left VA 
primary care practice. This natural experiment introduces an element of random assignment to 
NP or MD care because the reassignment process necessarily depends in part on the panel 
capacities of other clinicians in the clinic, which is exogenous to a reassigned patient’s health. 
Additionally, we applied instrumental variables models, leveraging natural variation in the 
supply of NPs at VA facilities to increase the plausibility of inferences derived from our primary 
quasi-experimental approach. The comparison of outcomes between patients receiving primary 
care from NPs compared to MDs can inform health systems and policymakers on whether NPs 
can effectively meet the increasing primary care demand in the U.S. at comparable cost and 
quality.
METHODS
Data and Study Sample
We conducted a retrospective cohort study using VA electronic health records from the 
VA Corporate Data Warehouse (CDW). PCPs and patients were identified from the Primary 
Care Management Module (PCMM), which contains longitudinal data on all VA primary care 
panels and tracks PCPs by type (e.g. MDs and NPs). Primary care at the VA is team-based. 
PCMM allows VA administrators to define PCP-led teams and assign patients to a specific PCP. 
National guidelines recommend a target panel size of 1200 for MDs and 900 for NPs. Panel size 
can be adjusted based on patient and facility characteristics.
We present the algorithm for deriving the study sample in Figure 1. We first identified 
primary care MDs who left VA primary care practice from 2010 to 2012, defined as those MDs 
without a patient panel for two consecutive quarters. We then identified all patients assigned to 
these MDs who were subsequently reassigned to a new PCP. We then applied several exclusions 
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sample consisted of 806,434 patients in 530 VA facilities, of whom 696,404 patients had a new 
MD PCP (hereafter MD patients) and 110,030 had a new NP PCP (hereafter NP patients). 
To assess clinical outcomes for quality of care, we identified three disease-specific 
cohorts from the final sample based on one outpatient or inpatient diagnosis code in the year 
prior to the PCP reassignment: diabetes (n=388,231: 26,363 NP patients and 180,934 MD 
patients), ischemic heart disease (IHD) (n=113,260: 14,413 NP patients and 98,847 MD 
patients), and hypertension (n=357,987: 45,806 NP patients and 312,181 MD patients). 
Study Design and Explanatory Variables
We employed a difference-in-difference approach, leveraging natural variation arising 
from the reassignment of patients whose provider left VA primary care practice. The 
independent variable of interest was a binary measure denoting type of PCP that patients were 
reassigned to, as indicated within PCMM (=0 for reassignment to an MD and =1 for 
reassignment to an NP). Other than PCP panel capacity, there is no national guidance on how to 
reassign a patient to a PCP. To facilitate comparisons in pre-post changes between groups, we 
interacted the indicator for reassignment to NP with a second indicator denoting time period (=1 
for post reassignment, =0 for pre reassignment).  
Outcome Measures
We examined nine utilization and cost outcome categories using VA administrative data 
capturing patient encounters during one year after the reassignment to a new PCP. 
Utilization and Cost Measures
We assessed three types of outpatient utilization: primary care, which includes visits at 
Geriatrics Primary Care and Comprehensive Women’s Primary Care clinics; specialty care; and 
mental health visits. Classification of outpatient visits was based on VA clinic stop codes, which 
identify the type of services rendered at a specific physical location (e.g. primary care, 
cardiology, psychiatry, etc.).18 We examined 1) a binary measure denoting whether patients had 
any visits in a given year and 2) number of visits among users for each outpatient visit type. 
We assessed two measures of inpatient utilization: any inpatient admission and any 
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conditions for which high quality outpatient care can potentially prevent hospitalization.19 If NPs 
provide a different quality of care compared to MDs, we would expect higher rates of 
hospitalization, particularly for PQIs, and that MD-NP differences would increase with patient 
complexity. 
Two cost measures were assessed: total outpatient cost and total cost, both measured 
using VA’s Managerial Cost Accounting System, an activity-based cost allocation system that 
generates estimates of the cost of individual VA hospital stays and healthcare encounters.20 All 
cost estimates were inflation adjusted to 2016 dollars using the Consumer Price Index.21  
Finally, we examined whether patients received two types of diagnostic tests, metabolic 
panel and echocardiogram or stress test, which were identified using a previously developed 
algorithm classifying categories of CPT procedure codes.22,23 Previous studies have suggested 
that NPs order more diagnostic tests and imaging.24,25  We hypothesized that NPs, who may have 
fewer years of formal training than MDs, were more likely to order diagnostic tests that are more 
frequent and low cost (metabolic panel), as well as less frequent and high cost (echocardiogram 
or stress test), particularly for newly assigned patients. The diagnostic tests are not disease-
cohort specific. 
Clinical Quality
We examined eight process and outcome measures routinely used by VA to measure the 
quality of primary care.26,27 Four measures were assessed for the diabetes cohort: 1) receipt of 
any hemoglobin A1c (HbA1c) test, 2) normal HbA1c defined as HbA1c<9%, 3) receipt of any 
low-density lipoprotein (LDL) measure, and 4) normal LDL defined as LDL<100 mg/dL. For 
HbA1c or LDL, we used the value of the last measure if there were multiple measures in a given 
year. Two measures were assessed for the IHD cohort: 1) receipt of any LDL test, and 2) normal 
LDL defined as LDL<100 mg/dL. Two measures were assessed for the hypertension cohort: 1) 
record of any blood pressure (BP) measurement, and 2) normal BP defined as systolic BP<140 
mmHg and diastolic BP<90 mmHg.26
Control Variables
We controlled for a large set of confounders that may potentially influence outcomes and 
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status), exemption from VA copayments, non-VA health coverage (Medicaid and Medicare), 
distance to the closest VA facility, geographic locations (urban/rural, Census division), length of 
time with the new PCP (<90 days, 91-180 days, 181-270 days, 271-365 days, >365 days), 
facility type (VA Medical Center [VAMC] versus CBOC), MD supply in the parent VAMC 
(number of full-time equivalent MDs/1,000 patients), and baseline comorbidity measures. The 
baseline period was defined as one year prior to the assignment of the new PCP. We controlled 
for comorbidity using the validated Gagne index, which is a composite weighted average of 20 
conditions derived by combining conditions in the Charlson28 and Elixhauser29 comorbidity 
scores.30 We controlled for the number of drug classes of prescriptions taken by patients, and an 
indicator denoting the presence of any psychiatric condition. Finally, we included lagged 
outcomes for all outcomes; lagged values for LDL and HbA1c were coded as high, normal or not 
present. 
Statistical Analysis
We applied generalized linear models (GLMs) to estimate differences in outcomes 
between patients reassigned to NPs and MDs. We modeled binary outcomes (any outpatient 
visits, hospitalizations, diagnostic tests, and meeting of clinical quality measures) using GLMs 
assuming a binomial distribution and a logit-link. For counts of outpatient visits, we assumed a 
negative-binomial distribution and a logit link. For cost outcomes, we integrated GLMs within 
two-part models to account for the large proportion of zero observations.31,32 In the first part, we 
modeled whether patients incurred non-zero costs as a binary outcome using the assumptions 
described above. In the second-part model, we modeled the number of visits among non-zero 
observations using GLM assuming a gamma distribution and a log link, which were determined 
using the Pregibon Link test33 and the modified Park test.34 For all outcomes, we examined 
whether differences in outcomes varied by level of patient comorbidity by interacting Gagne 
score categories (<0, 0-2, 3-10, and 11) with indicator variables for reassigned PCP type and 
period. Standard errors for GLM parameter estimates were estimated using a bootstrap procedure 
with 1,000 replications. All standard error estimates adjusted for intracluster correlation at the 
facility level.
For inference, we calculated average marginal effects (AMEs), which reflect average 
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the probability scale for dichotomous outcomes, visit counts for utilization measures and dollars 
for cost measures. For analyses of differential effects, we estimated AMEs conditional on the 
four levels of comorbidity. Standard errors for AME estimates were estimated using the delta 
method, and all hypotheses tests assumed a nominal p-value of 0.01 due to multiple 
comparisons. 
We conducted sensitivity analyses by applying instrumental variable (IV) models to 
explore the potential for unobserved confounders affecting PCP assignment and outcomes. This 
approach seeks to isolate the pseudo-random component of PCP assignment that is related to an 
IV and not correlated with unobserved variables influencing the outcome.35 The IV we employed 
was the proportion of NPs (the number of NPs/the total number NPs and MDs) at VA primary 
care clinics. The set of NPs from which the VA can hire is smaller in states with more restrictive 
NP scope of practice.9 We hypothesized the IV would be strongly correlated with the 
explanatory variable as greater availability of NPs at a clinic should increase the probability of 
being reassigned to an NP. We also hypothesized that after controlling for clinic characteristics, 
the proportion of NPs should be uncorrelated with unobserved variables affecting outcomes as a 
result of this variation in the IV influenced by state laws.
For dichotomous outcomes, we implemented the IV approach using bivariate probit 
models. In these models, the probability of being reassigned to an NP and the probability of a 
positive outcome were estimated as separate, but correlated outcomes. NP reassignment was 
estimated as a function of the IV (i.e., the proportion of PCPs at a clinic that were NPs) and 
control variables. Dichotomous patient outcomes were simultaneously modeled as a function of 
NP reassignment and control variables. Instrument strength was assessed by comparing the 
partial F-statistic for the IV with a cutoff of 10, defined by previous studies as a minimum 
threshold.36 For IV models with dichotomous treatment and outcome variable, the bivariate 
probit model has been shown to minimize bias when estimating average treatment effects.37
For continuous outcomes, IV models were implemented using the two-stage residual 
inclusion estimator.38 In the first stage, we modeled NP reassignment as a function of the IV and 
control variables using a GLM with a binomial distribution and logit link. We then estimated the 
second stage as a function of NP reassignment, control variables and the response residual from 
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probability of NP reassignment. For utilization and cost analyses, two-stage residual inclusion 
was applied to each part of the two-part model previously specified. 




In Table 1, we report standardized differences, which compare means in units of the 
pooled standard deviation and can be used to compare balance in measured variables. With few 
exceptions, standardized differences in patient characteristics between patients reassigned to NPs 
and MDs were below 10, indicating negligible differences between the two groups.39,40 Both 
groups had a mean age of 62 years and exhibited small differences in VA copayment status, 
Medicaid and Medicare coverage, and comorbidity. Compared to MD patients, NP patients were 
less likely to be black (17.4% versus 13.2%) and stay with the new PCP for more than 1 year 
(41.7% versus 46.6%). 
There were larger differences in rural/urban and geographic regions between the two 
groups. NP patients were more likely to reside in the Midwest than MD patients (30.0% versus 
19.0%), while MD patients were more likely to reside in the South than NP patients (50.4% 
versus 32.4%). NP patients were more likely to reside in rural areas than MD patients (23.9% 
versus 14.7%). While there were 53% of VAMC patients in the both groups, MD patients were 
more likely to be with a parent VAMC with more greater MDs, including primary care and 
surgical and non-surgical specialists, than NP patients. For baseline period outcomes, 
standardized differences were less than 10 for all measures. 
Utilization and Cost Outcomes
 Descriptive analysis: The only outcome with a standardized difference greater than 10 
was use of specialty care (Table 2). Most patients had at least one primary care visit (91.5% for 
NP patients versus 92.7% for MD patients). About one-third had 1 specialty care visit (31.2% 
for NP patients versus 36.5% for MD patients). Less than 30% had 1 mental health visit (28.1% 















This article is protected by copyright. All rights reserved
test (63.2% for NP patients versus 64.5% for MD patients), while only a small proportion had 
any echocardiogram or stress test (4.6% for NP patients versus 5.0% for MD patients). 
Fewer than 1-in-10 patients had any hospitalization (7.9% for NP patients versus 8.9% 
for MD patients). Any hospitalization for PQIs were 1.1% for NP patients and 1.3% for MD 
patients, respectively. Mean VA outpatient costs were $4,447 for NP patients compared to 
$4,894 for MD patients. Mean total VA costs were $6,972 for NP patients and $7,432 for MD 
patients. 
Multivariable analysis: The first-part results showed that NP patients were less likely to 
have at least one primary care visit (AME=-1.33 percentage points, 99% CI: -1.92 to -0.68 
percentage points) and any specialty care (AME=-2.19 percentage points, 99% CI: -3.10 to -1.33 
percentage points) than MD patients. Count models showed that NPs patients had fewer primary 
care visits (AME=-0.36 visits, 99% CI: -0.31 to -0.07) and specialty care visits (AME=-0.19 
visits, 99% CI: -0.35 to -0.03) than MD patients among respective subpopulations of patients 
using each service type. We did not identify statistically significant differences in use of mental 
health services. 
In the analysis of differential effects across level of comorbidity, the probability of at 
least one primary care visit was lower for NP patients, compared to MD patients with a Gagne 
score from 0-2 (AME=-1.76 percentage points, 99% CI: -2.74 to -0.79) (Figure 2). Among users 
of primary care, NP reassignment was associated with fewer primary care visits for patients with 
a Gagne score <0 (AME=-0.37 visits, 99% CI: -0.60 to -0.15) and from 0-2 (AME=-0.35 visits, 
99% CI: -0.55 to -0.14), respectively (Appendix, Table 1). The probability of 1 specialty care 
visit was 2.63 (99% CI: -4.12 to -1.11) and 2.15 (99% CI: -3.31 to -0.99) percentage points lower 
for NP patients with a Gagne score <0 and 0-2, respectively, relative to analogous patients 
reassigned to MDs. Among users of specialty care, NP reassignment was associated with fewer 
visits for patients with a Gagne score from 0-2 (AME=-0.18 visits, 99% CI: -0.33 to -0.03) and 
from 2-5 (AME=-0.32 visits, 99% CI: -0.60 to -0.04), respectively.
 NP patients were less likely to have any hospitalization (AME=-0.86 percentage points, 
99% CI: -1.37 to -0.34) and any PQI hospitalization (AME= -0.19 percentage points, 99% CI: -
0.37 to -0.06). The interaction terms between provider type and Gagne score categories showed 
consistent NP-MD differences across levels of comorbidity, with most of the effects occurring in 
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metabolic panel test, any diagnostic echocardiogram or stress test, and total VA cost in both 
main effect and differential effect estimates. The significant differences in use but not costs were 
likely due to the relatively small differences in use and the large variance in cost. Finally, while 
NP reassignment was not associated with outpatient costs overall, a statistically significant 
difference was identified among patients with a Gagne score from 3-10 (AME=-$341, 99% CI: -
$579 to -$104).
The first stage of the IV model found a partial F-statistic on the instruments of 36.3. 
Overall, IV models produced wider CIs than GLM models (Appendix, Table 2). As a result, no 
statistically significant differences between NP and MD patients were identified. However, AME 
estimates for use of primary care and specialty care were directionally similar to analogous GLM 
estimates. 
Clinical Outcomes
Descriptive analysis: All standardized differences in clinical outcomes were less than 10, 
indicating negligible differences between NP and MD patients (Table 3). Among the diabetes 
cohort, the majority of patients had any HbA1c test (87.9% for NP patients versus 89.3% for MD 
patients), normal HbA1c (87.9% for NP patients versus 87.6% for MD patients), any LDL test 
(84.7% for NP patients versus 85.6% for MD patients), and normal LDL (70.4% for NP patients 
versus 71.7% for MD patients). Among the IHD cohort, the majority had any LDL test (80.7% 
for NP patients versus 82.7% for MD patients) and normal LDL (74.1% for NP patients versus 
75.6% for MD patients). Among the hypertension cohort, almost all patients had a BP measure 
(97.4% for NP patients versus 97.7% for MD patients) and the majority had normal BP (72.1% 
for NP patients versus 72.9% for MD patients). 
Multivariable analysis: Both the GLM and IV analysis indicated NP-MD differences in 
clinical outcomes were not statistically significant across all measures (Table 3). 
DISCUSSION
This study conducted a comprehensive assessment of economic and clinical outcomes 
between primary care NPs and MDs in the VA system. Study findings suggest utilization and 
cost of NP primary care were largely comparable to MD primary care.12,41 While prior studies 
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reductions in use of primary care and specialty care among patients reassigned to NPs relative to 
comparable patients reassigned to MDs. The marginal effects for use of any primary care and 
specialty care translated to 1.4% and 6.1% of the respective means. Similarly, we found NP 
patients were less likely to have any hospitalization overall and for PQIs than MD patients. 
While the differences were small, these findings are consistent with other studies.41-44
One potential explanation for fewer hospitalizations, especially for PQIs, may be 
increased access to NP providers due to their smaller panel size. An NP’s panel size at VA is 
expected to be 75% of an MD’s in order to give NPs sufficient time to manage their patients.45 
Reduced panel size may translate to greater access and time spent with individual patients, which 
in turn may translate into fewer hospitalizations. Differences in utilization were present across 
the risk distribution, suggesting NPs may be effective at reducing outpatient utilization and 
hospitalizations for different subpopulations of patients.  
The novel approach employed in this study compared outcomes of care provided by NPs 
and MDs using natural variation arising from the reassignment of patients following the 
departure of an existing provider. Characteristics of patients reassigned to NPs and MDs were 
generally balanced, which is supportive of pseudo-random reassignment. Nevertheless, we 
conducted sensitivity analyses using IV models to address the potential for other unobserved 
confounders, finding outcomes among NP patients were no worse than those of MD patients. 
However, IV models have the limitation of less precise AME estimates. 
In contrast to prior studies that showed NPs were more likely to order tests,14,46-49 this 
study showed no significant differences in the ordering of two diagnostic tests (metabolic panel 
and echocardiogram or stress test). Previous studies show mixed results in cost of NP care,14,50-54 
while our study shows that NP and MD patients had similar outpatient cost and total cost. 
Finally, we found NPs and MDs achieved similar clinical outcomes among patients with chronic 
diseases, including diabetes, IHD, and hypertension, which is consistent with prior VA and non-
VA studies.2,17,55-57  
Several systematic reviews have highlighted the challenges in summarizing the literature 
examining outcomes between patients receiving care from NPs compared to MDs because of 
methodological limitations, including small sample sizes.12,42  Our study extends previous 
research with several methodological contributions. First, we addressed patient selection bias by 
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left VA primary care practice. This is important because provider reassignment likely introduced 
some pseudo-random variation into the type of provider responsible for patients’ primary care. It 
is pseudo-random in that at least some of the assignment was due to idiosyncratic operational 
considerations (e.g. patients assigned to whichever PCPs have slots available for new patients) 
rather than to specific characteristics of the patient that might affect healthcare outcomes. 
Although we do not observe the decision process for reassigning patients, the average MD PCP 
panel at the VA consists of 1200 patients; reassignment of this many patients based on 
characteristics of the patient would be a complex undertaking for a busy clinic. Second, this 
study examined a large, nationally representative cohort of 806,434 patients and assessed 
outcomes in one year after reassignment to a new PCP. This expands on prior research that 
examined utilization and clinical outcomes simultaneous to provider assignment.2 Finally, we 
identified patient-PCP relationships using panel assignments tracked within VA administrative 
data. PCPs in VA are responsible for managing overall health of their patient panel, irrespective 
of whether a patient receives care from a different PCP at a given encounter. Specifically, PCPs 
are evaluated on whether they meet specific performance targets for their patient panel.58 This 
improves on prior research that assigns patients based on the provider of record for a single 
encounter or the provider rendering the majority of visits, which may not reflect the provider 
responsible for managing the patient’s care. 
The VA system provides a unique environment to assess effectiveness of care provided 
by NPs and offers several advantages. Because NPs comprise approximately 20% of all PCPs in 
VA, there is sufficient sample size to examine differences in outcomes between patients 
managed by MDs and NPs and to explore whether differences vary across patient 
charactierstics.2 Like MDs, VA primary care NPs have their own patient panels and have 
independent practice authority. The VA is federally funded and, while it bills third party payers, 
the vast majority of its funding is from federal appropriations. In addition, the VA electronic 
health records system comprehensively captures services provided by NPs, identified in 
administrative data using distinct provider type codes. In contrast, commercial or Medicare 
claims may underestimate care provided by NPs because of higher reimbursement rates for MDs; 
a significant proportion of NP services are billed through their supervising MDs.59 
Taken together, study findings suggest that the general use of NPs as primary care 
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as a top VA priority.60 We also found that comparable or better outcomes achieved at similar 
costs for patients across differing levels of comorbidity, suggesting NPs as PCPs need not be 
limited to less complex patients. For health systems deciding how to expand capacity, 
consideration should also be given to differences in labor costs, panel sizes and spillover effects 
outside of primary care, such as referrals, each of which were outside the scope of this study. 
Future research should also examine potential heterogenous differences in outcomes between 
patients reassigned to NPs versus MDs across subpopulations defined by characteristics other 
than comorbidity. 
This study has several limitations. First, this was an observational study, not a 
randomized controlled trial. However, we applied methodological approaches to improve causal 
inference including the use of a study design that leveraged pseudo-random variation in patient 
assignment to primary care providers introduced through the attrition of VA PCPs who left 
primary care practice, in order to address potential patient selection bias. Sensitivity analyses 
using IV methods also supported the finding that care provided by NPs was at least comparable 
to MDs. Second, this study examined the population of VA primary care patients, which may 
differ from other non-VA populations because of unique VA enrollment requirements (e.g. prior 
military service). However, prior research has found similarity between VA and non-VA 
populations, including Medicare.61  Third, we did not measure differences between NP and MD 
patients in their satisfaction with their PCP, and we did not measure requests to be reassigned to 
a new PCP. Fourth, we assumed that the administratively reassigned PCP was responsible for 
differences in patient outcomes; we did not address the extent to which other clinicians in 
primary or specialty care helped orchestrate a patient’s care. Fifth, future studies should assess 
whether differences in clinical outcomes are evident over follow-up times longer than the 1 year 
in the present study. Finally, we did not observe healthcare use provided by community 
providers through a Veteran’s Medicare benefits. This could affect the results if patients 
reassigned to MDs and NPs differed in their subsequent reliance on the VA for care.
In conclusion, this study shows that NP patients did not differ from MD patients in VA 
healthcare costs, but had less utilization of primary care, specialty care and inpatient services. 
Further, NP and MD reassigned patients achieved similar quality of care in chronic disease 
management. This study supports the evidence that use of NPs can improve access to primary 
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Insert figure 1 here
Figure 2. Differences in utilization between NP and MD patients by level of comorbidity. 
Insert figure 2 here
Table 1. Baseline patient characteristics of patients reassigned to NPs and MDs. 
NP (n=110,030) MD (n=696,404)
 Mean or %    SD Mean or % SD
Std. Diff.
(NP-MD)
Age (mean, years) 62.3 15.5 62.0 15.1 1.6
Age ≥ 65 (%) 45.9 49.8 44.7 49.7 2.6
Female (%) 7.7 26.7 6.2 24.1 5.9
Race
  White (%) 78.2 41.3 74.0 43.9 9.8
  Black (%) 13.2 33.8 17.4 37.9 -11.8
  Other (%) 4.6 2.1 4.9 21.7 -1.5
  Unknown (%) 4.0 19.6 3.6 18.7 2.1
Ethnicity: Hispanic (%) 4.3 20.2 6.2 24.2 -8.9
VA Copayment status 
  Copay Exempt due to Disability (%) 42.3 49.4 43.5 49.6 -2.2
  Copay Exempt due to low Income (%) 36.3 48.1 37.4 48.4 -2.2
  No Copay Exempt (%) 21.3 41.0 19.1 39.3 5.4
Married (%) 55.9 49.6 55.1 49.7 1.6
Distance to the closest VA facility 
  <5 miles (%) 22.7 41.9 21.6 41.1 1.1
  5-10 miles (%) 16.8 37.4 19.5 39.6 -7.0
  11-20 miles (%) 17.5 38.0 20.4 40.3 -7.3
  21-40 miles (%) 18.7 39.0 17.5 38.0 3.2
  >40 miles (%) 24.0 42.7 20.8 40.6 7.7
  Missing distance 0.3 5.5 0.3 5.4 0.3
Medicaid (%) 3.6 18.5 3.3 17.9 1.3
Medicare coverage
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   HMO (%) 10.0 30.0 9.9 29.9 3.0
   No Medicare (%) 51.7 50.0 53.0 49.9 -2.5
Any Psychiatric Condition (%) 47.6 49.9 48.5 50.0 -1.8
Comorbidity-Gagne score
  <0 (%) 21.1 40.8 21.2 40.9 -0.3
  1-2 (%) 67.7 46.8 67.0 47.0 1.5
  3-10 (%) 11.1 31.4 11.6 32.0 -1.8
  11+ (%) 0.2 4.4 0.2 4.3 0.2
NOSOS Risk score 0.56 0.97 0.58 0.95 -0.02
Diabetes cohort (%) 24.0 42.7 26.0 43.9 -4.7
Ischemic heart disease cohort (%) 13.1 33.8 14.2 34.9 -3.1
Hypertension cohort (%) 41.6 49.3 44.8 49.7 -6.5
Length of time with new provider
  <90 days (%) 20.6 40.4 21.8 41.3 -3.0
  90-179 days (%) 15.2 35.9 11.5 31.9 10.9
  180-269 days (%) 11.5 31.9 10.4 30.5 3.7
  270-364 days (%) 11.0 31.2 9.7 29.6 4.0
  ≥365 days (%) 41.7 49.3 46.6 49.9 -9.8
Region
  West (%) 27.7 44.8 22.6 41.8 5.7
  Midwest (%) 30.0 45.8 19.0 39.2 25.9
  South (%) 32.4 46.8 50.4 50.0 -37.2
  Northeast (%) 9.9 29.8 8.0 27.1 6.6
Rural (%) 23.9 42.7 14.7 35.5 23.4
Facility type: VAMC (%) vs CBOC 53.1 49.9 52.7 49.9 0.8
FTE MDs/1,000 patients at parent VAMC
  Non-Surgical Specialists 47.6 21.1 53.3 19.6 -29.9
  Surgical Specialists 30.6 15.9 36.0 15.3 -35.1
  Primary Care 77.1 15.2 80.9 14.8 -22.7
Outcome data collected in baseline period
Any visit (%)
  Primary care 90.7 29.0 90.4 29.5 1.2
  Specialty care 34.0 47.4 38.0 48.5 -8.3
  Mental health 27.9 44.9 28.8 45.3 -1.9
Number visits (mean)
  Primary Care 4.5 4.9 4.6 4.9 0.0
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  Mental health 4.3 18.7 4.3 18.1 0.0
Test or procedure (%)
  Any metabolic panels 62.9 48.3 65.4 47.6 -5.3
  Any echocardiogram or stress test 3.9 19.4 4.8 21.3 -4.1
Hospitalization (%)
   Any hospitalization 7.9 27.0 8.9 28.4 -3.4
   Any PQI 1.1 10.4 1.2 11.0 -1.3
VA Costs ($)
  Outpatient costs 4,096 6,900 4,659 7,941 -0.08
  Total costs 6,385 18,943 7,111 24,007 -0.03
Clinical outcomes: diabetes (%)
  Any HbA1c 86.4 34.2 87.5 33.0 -3.2
  HbA1c control: HbA1c<9% 87.5 33.0 87.1 33.5 1.3
  Any LDL 83.1 37.5 83.7 36.9 -1.6
  LDL control: LDL<100 71.2 45.3 72.8 44.5 -3.5
Clinical outcomes: IHD (%)
  Any LDL 78.0 41.5 79.8 40.2 -4.4
  LDL control: LDL<100 74.3 43.7 76.3 42.5 -4.7
Clinical outcomes: hypertension (%)
  Any BP measure 94.4 23.0 94.3 23.1 0.4
  BP control
  Systolic<140 & diastolic<90 73.1 44.4 73.0 44.4 0.3
NP=nurse practitioner, MD=medical doctor, Std. Diff.=standardized difference, VA=Veterans Affairs, HMO=health 
maintenance organization, VAMC=VA Medical Center, CBOC=community-based outpatient clinic, FTE=full time 
equivalent, PQI=prevention quality indicator, HbA1c=hemoglobin A1c, LDL=low-density lipoprotein, 
IHD=ischemic heart disease, BP=blood pressure
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     Specialty care 31.2 36.5 -11.3 -2.19**
[-3.35, -1.03]
     Mental health 28.1 28.9 -0.2 -0.06
[-0.88, 0.76]
Number of visits among users by type of visit (counts)
     Primary care 4.54 4.86 -0.1 -0.36**
[-0.58, -0.13]
     Specialty care 4.53 4.91 -0.06 -0.19*
[-0.35, -0.03]
     Mental health 14.87 14.86 0.003 -0.46
[-1.07, 0.14]
Any test or procedure (%)
     Any metabolic panels 63.2 64.5 -0.2 0.04
[-4.83, 4.06]
     Any echocardiogram or stress test 4.6 5.0 -1.9 -0.22
[-0.71, 0.28]
Inpatient utilization (%)
     Any inpatient 7.9 8.9 -3.7 -0.86**
[-1.37, -0.34]
     Any inpatient for PQIs 1.1 1.3 -2.3 -0.21**
[-0.37, -0.06]
Costs
     Outpatient costs $4,447 $4,894 -0.06 -$98
[-251, 55]
     Total costs $6,972 $7,432 -0.02 -$289
[-696, 117]
*p<0.01; **p<0.001
NP=nurse practitioner, MD=medical doctor, SMD=standardized mean difference, Adj. Diff=adjusted difference, 
PQI=prevention quality indicator
Table 3: Differences in clinical outcomes between patients reassigned to NPs and MDs.
Unadjusted
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Outcome (NP-MD)  (NP-MD) 
[99% CI]
Diabetes Cohort (n=26,363) (n=180,934)
     Any HbA1c Test (%) 87.9 89.3 -4.4 -1.00
[-2.15, 0.17]
     HbA1c control: 
     HbA1c<9 (%)
87.9 87.6 -0.9 -0.02
[-0.72, 0.69]
     Any LDL (%) 84.7 85.6 -2.4 -0.25
[-2.16, 1.66]
     LDL control: LDL<100 (%) 70.4 71.7 -2.7 -0.60
[-1.75, 0.55]
Ischemic Heart Disease  (n=14,413) (n=98,847)
     Any LDL Test (%) 80.7 82.7 -5.2 -0.71
[-2.88, 1.45]
     LDL control: LDL<100 (%) 74.1 75.6 -3.6 -0.70
[-1.85, 0.46]
Hypertension (n=45,806) (n=312,181)
     Any BP measurement (%) 97.4 97.7 -2.4 -
     BP control (%):
     systolic<140 & diastolic<90
72.1 72.9 -1.8 -0.74
[-2.22, 0.74]
*p<0.01; **p<0.001
NP=nurse practitioner, MD=medical doctor, SMD=standardized mean difference, Adj. Diff=adjusted difference, 
HbA1c=hemoglobin A1c, LDL=low density lipoprotein, BP=blood pressure
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